Venture Capital Firm CerraCap Ventures Acquires Predicta Med
CerraCap Ventures announced on February 10 an investment in Predicta Med. Terms of the deal were not disclosed. Headquartered in Tel Aviv, Israel, Predicta Med is an AI-based digital health company in the field of predictive analytics. The company helps medical clinics and institutions identify immune-related diseases. CerraCap Ventures is a Costa Mesa, California-based venture capital firm dedicated to early-stage technology investments in enterprise B2B solutions, including cybersecurity and health care. According to data captured in the LevinPro HC database, this acquisition represents the 16th Laboratories, MRI and Dialysis transaction of 2023 and the ninth in the diagnostics... Read More »
GE Healthcare Acquires Caption Health
GE Healthcare has acquired Caption Health, Inc. The transaction is subject to customary closing conditions. Financial terms of the deal are not being disclosed. GE Healthcare intends to fund this transaction with cash on hand. Caption Health is a privately owned artificial intelligence (AI) healthcare company that creates clinical applications to aid in early disease detection, using AI to assist in conducting ultrasound scans. GE Healthcare, a subsidiary of GE, manufactures and distributes diagnostic imaging agents and radiopharmaceuticals for imaging modalities that are used in medical imaging procedures. According to data captured in the LevinPro HC database, this acquisition represents... Read More »
Evolution Dental Science Purchases Pro-Esthetics Dental Laboratory
Evolution Dental Science, based in Buffalo, New York, announced its acquisition of Pro-Esthetics Dental Laboratory. The acquisition of Pro-Esthetics, plus an affiliation with national dental service organization Heartland Dental, is expected to lead to another 30% to 40% growth for 2023 for Evolution Dental Science. The financial terms of the acquisition were not disclosed. Pro-Esthetics Dental Laboratory is a full-service laboratory that manufactures dental products such as crowns, bridges and implants. The company is based in Concord, Ontario. Evolution Dental Science has been one of the most trusted dental laboratories since its founding in 1993. Evolution has evolved itself over... Read More »
Biosynex to Acquire Chembio Diagnostics for $17.2 Million
Biosynex SA and Chembio Diagnostics, Inc. have entered into a definitive merger agreement under which Biosynex, through a subsidiary, will acquire Chembio in an all-cash transaction valued at $17.2 million. Ernst & Young LLP is acting as financial advisor and White & Case LLP is serving as legal counsel to Biosynex. Craig-Hallum Capital Group is acting as financial advisor and K&L Gates LLP is serving as legal counsel to Chembio. Chembio Diagnostics is a Medford, New York-based point-of-care diagnostics company focused on infectious diseases, including sexually transmitted infections, respiratory viruses and fever and tropical disease. Chembio’s total revenue for 2021 was... Read More »
Aegis Sciences Corporation Acquires HealthTrackRx Toxicology’s Business
Nashville-based Aegis Sciences Corporation announced that it acquired HealthTrackRx Toxicology’s line of business. HealthTrackRx is one of the nation’s premier polymerase chain reactions (RT-PCR)-based infectious disease laboratories. It was founded with a focus on clinical toxicology testing. Founded in 1990, Aegis Sciences Corporation is a laboratory sciences company that provides testing and consulting services to healthcare providers, pharmaceutical companies, professional and amateur sports organizations, college and university athletic programs, Fortune 500 corporations and government agencies throughout the United States. The financial terms of the acquisition were not... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
